MD Anderson receives $55 million over five years in comprehensive cancer center status renewal
The University of Texas MD Anderson Cancer Center received a notice of renewal from the National Cancer Institute (NCI) to extend its status as an NCI-designated comprehensive cancer center. The funding for the Cancer Center Support Grant (CCSG) provides a total of $55 million over five years.
MD Anderson was one of the first three cancer institutions to receive the designation and has been continually renewed since 1971. The NCI...
MD Anderson receives more than $19 million in CPRIT funding
The University of Texas MD Anderson Cancer Center today was awarded more than $19 million from the Cancer Prevention and Research Institute...
Boehringer Ingelheim and MD Anderson form unique virtual research and development center to rapidly advance new cancer therapies
Boehringer Ingelheim and The University of Texas MD Anderson Cancer Center today announced a new multi-year partnership to conduct collaborative...
Bacteria on tumors influences immune response and survival of patients with pancreatic cancer
A key difference between the few pancreatic cancer patients who survive long-term and the many whose disease overcomes all treatments is the bacterial signatures on their tumors that either stimulate or suppress immune response, a team led by researchers from The University of Texas MD Anderson Cancer Center reports in the journal Cell.
The researchers also showed that...
MD Anderson to expand Proton Therapy Center
The University of Texas MD Anderson Cancer Center unveiled plans to expand its Proton Therapy Center during a groundbreaking ceremony. The...